Hot Watch List: The Medicines Company (NASDAQ:MDCO), Omeros Corporation (NASDAQ:OMER), Northwest Biotherapeutics (NASDAQ:NWBO), Dehaier Medical Systems (NASDAQ:DHRM), Durata Therapeutics (NASDAQ:DRTX)

The Medicines Company (NASDAQ:MDCO) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported ($0.08) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.07) by $0.01. The company had revenue of $177.20 million for the quarter, compared to the consensus estimate of $175.60 million. During the same quarter last year, the company posted ($0.21) earnings per share. The … Continue reading Hot Watch List: The Medicines Company (NASDAQ:MDCO), Omeros Corporation (NASDAQ:OMER), Northwest Biotherapeutics (NASDAQ:NWBO), Dehaier Medical Systems (NASDAQ:DHRM), Durata Therapeutics (NASDAQ:DRTX)

Bluebirdbio BLUE NASDAQ BLUE

Healthcare Gainers: Gentiva Health Services (NASDAQ:GTIV), bluebird bio Inc (NASDAQ:BLUE), Celldex Therapeutics (NASDAQ:CLDX), Intercept Pharmaceuticals (NASDAQ:ICPT), Northwest Biotherapeutics (NASDAQ:NWBO)

Gentiva Health Services Inc. (NASDAQ:GTIV)’s rejection of the takeover proposal from Kindred Healthcare Inc. ( KND ) is hitting headlines and drawing investor attention to the healthcare space. Gentiva Health Services, Inc. (NASDAQ:GTIV) stock performance was -1.52% in last session and finished the day at $13.62. Traded volume was 1.47million shares in the last session and the average volume of the stock remained 471.48K shares. … Continue reading Healthcare Gainers: Gentiva Health Services (NASDAQ:GTIV), bluebird bio Inc (NASDAQ:BLUE), Celldex Therapeutics (NASDAQ:CLDX), Intercept Pharmaceuticals (NASDAQ:ICPT), Northwest Biotherapeutics (NASDAQ:NWBO)

Biotech Bullish Stocks: Merrimack Pharmaceuticals (NASDAQ:MACK), Sarepta Therapeutics (NASDAQ:SRPT), Northwest Biotherapeutics (NASDAQ:NWBO), Progenics Pharmaceuticals (NASDAQ:PGNX)

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) announced that it will present at the 2014 AACR Annual Meeting. The conference will take place on April 5-9, 2014 at the San Diego Convention Center in San Diego. Presentations will include a clinical pilot study evaluating the feasibility of using ferumoxytol* as an MRI imaging agent prior to MM-398 investigational treatment. Merrimack Pharmaceuticals Inc (NASDAQ:MACK) stock performance was 6.15% in … Continue reading Biotech Bullish Stocks: Merrimack Pharmaceuticals (NASDAQ:MACK), Sarepta Therapeutics (NASDAQ:SRPT), Northwest Biotherapeutics (NASDAQ:NWBO), Progenics Pharmaceuticals (NASDAQ:PGNX)

Biotech Gainers: Inovio Pharmaceuticals Inc (NYSEMKT:INO), Northwest Biotherapeutics (NASDAQ:NWBO), Peregrine Pharmaceuticals (NASDAQ:PPHM), Dyax (NASDAQ:DYAX)

Trade-Ideas LLC identified Inovio Pharmaceuticals Inc (NYSEMKT:INO) as a “barbarian at the gate” (strong stocks crossing above resistance with today’s range greater than 200%) candidate. Inovio Pharmaceuticals, Inc. (NYSEMKT:INO), together with its subsidiaries, engages in the discovery and development of synthetic vaccines and immune therapies focusing on cancers and infectious diseases. Currently there are 3 analysts that rate Inovio Pharmaceuticals Inc (NYSEMKT:INO) a buy, no … Continue reading Biotech Gainers: Inovio Pharmaceuticals Inc (NYSEMKT:INO), Northwest Biotherapeutics (NASDAQ:NWBO), Peregrine Pharmaceuticals (NASDAQ:PPHM), Dyax (NASDAQ:DYAX)

Biotech Top Losers: Geron Corporation (NASDAQ:GERN), Synta Pharmaceuticals (NASDAQ:SNTA), Northwest Biotherapeutics (NASDAQ:NWBO), AEterna Zentaris (NASDAQ:AEZS)

Geron Corporation (NASDAQ:GERN) said the US Food and Drug Administration ordered a halt to trials of a cancer drug over concerns about potential liver damage. Geron Corporation (NASDAQ:GERN) stock performance was -61.59% in last session and finished the day at $1.69. Traded volume was 46,444,384 million shares in the last session and the average volume of the stock remained 4.64 million shares. The beta of … Continue reading Biotech Top Losers: Geron Corporation (NASDAQ:GERN), Synta Pharmaceuticals (NASDAQ:SNTA), Northwest Biotherapeutics (NASDAQ:NWBO), AEterna Zentaris (NASDAQ:AEZS)

Biotech Unusual Volume: Northwest Biotherapeutics (NASDAQ:NWBO), La Jolla Pharmaceutical Company (NASDAQ:LJPC), OXiGENE (NASDAQ:OXGN), Tengion (OTCMKTS:TNGN)

Northwest Biotherapeutics Inc (NASDAQ:NWBO) a biotechnology company developing DCVax personalized immune therapies for solid tumour cancers, has received approval from the Paul Ehrlich Institute (PEI- the FDA of Germany) of a “Hospital Exemption” early access programme under Section 4b of the German Drug Law. Northwest Biotherapeutics, Inc (NASDAQ:NWBO) stock performance was 16.93% in last session and finished the day at $9.18. Traded volume was 8,391,894 … Continue reading Biotech Unusual Volume: Northwest Biotherapeutics (NASDAQ:NWBO), La Jolla Pharmaceutical Company (NASDAQ:LJPC), OXiGENE (NASDAQ:OXGN), Tengion (OTCMKTS:TNGN)